Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Does the Forecast Indicate for the Alpha Glucosidase Inhibitors Market From 2025 to 2029?

The market size of alpha glucosidase inhibitors has seen significant growth over the years. The market is predicted to expand from $4.52 billion in 2024 to $4.84 billion in 2025, with a compound annual growth rate (CAGR) of 7.0%. The surge during the historic period is due to a rise in diabetes cases, enhanced comprehension of diabetes management, progression in diabetes treatment tactics, a preference for orally administered antidiabetic medications, and the impact of clinical research and evidence-based medicine.

The market size of alpha glucosidase inhibitors is projected to witness robust growth in the coming years, expanding to a value of $6.49 billion by 2029 with a compound annual growth rate (CAGR) of 7.6%. This growth during the forecast period is ascribed to factors such as increased focus on early intervention, rising elderly population, worldwide healthcare initiatives targeting diabetes management, and inclusion in combination therapies. The forecast period also sees key trends such as patient-oriented approaches, emphasis on managing type 2 diabetes, advancements in drug delivery technology, the emergence of new markets and globalization, as well as collaborations and partnerships.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11880&type=smp

What Elements Are Contributing To Growth In The Alpha Glucosidase Inhibitors Market?

The global increase in diabetes incidence is anticipated to boost the alpha-glucosidase inhibitors market’s expansion. Diabetes is a chronic metabolic disorder characterized by elevated blood sugar levels that, over time, can severely damage the heart, blood vessels, eyes, kidneys, and nerves. Alpha-glucosidase inhibitors obstruct the absorption of carbohydrates in the small intestine, which helps in managing diabetes by preventing a post-meal spike in blood sugar levels. For example, the Belgium-based International Diabetes Federation reported in November 2022 that globally, 537 million adults (or 1 in 10) were affected by diabetes. Additionally, the global incidence of diabetes is projected to rise by 643 million people by 2030 and 783 million people by 2045. Hence, the worldwide increase in diabetes cases is fueling the expansion of the alpha-glucosidase inhibitors market.

Which Segments Are Detailed In The Global Alpha Glucosidase Inhibitors Market Report?

The alpha glucosidase inhibitors market covered in this report is segmented –

1) By Type: Dumping Syndrome, Type 2 Diabetes

2) By Drug Class: Acarbose, Miglitol, Voglibose

3) By Constituent: Glucoamylase, Isomaltase, Maltase, Sucrase

4) By Distribution Channel: Online Pharmacies, Retail Pharmacies, Hospital Pharmacies

Subsegments:

1) By Dumping Syndrome: Post-Gastric Surgery Management, Symptomatic Treatment

2) By Type 2 Diabetes: Monotherapy, Combination Therapy

Which Emerging Trends And Strategic Shifts Are Shaping The Alpha Glucosidase Inhibitors Market?

A crucial trend gaining traction in the alpha-glucosidase inhibitors market is product innovation. Major players in the alpha-glucosidase inhibitors sphere are engineering unique products to maintain their market stronghold. For example, in January 2023, U.S. pharmaceutical firm, TheracosBio, was granted an approval by the U.S. Food and Drug Administration (FDA) for Brenzavvy (bexagliflozin), a novel oral inhibitor of sodium-glucose cotransporter 2 (SGLT2), to manage adults with type 2 diabetes. Brenzavvy is recommended as an addition to routine diet and physical activity. It assists individuals with type 2 diabetes to effectively control their blood sugar levels by prompting the kidneys to eliminate sugar via urine.

Who Are The Key Contributors To Growth In The Alpha Glucosidase Inhibitors Market?

Major companies operating in the alpha glucosidase inhibitors market include Bayer AG, Merck & Co., Alkem Laboratories Ltd., Cipla Limited, Dr. Reddy’s Laboratories Ltd., Emcure Pharmaceuticals Ltd., Lupin Ltd., Novartis AG, Sanofi SA, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company, Torrent Pharmaceuticals Ltd., Unichem Laboratories Ltd., Pfizer Inc., Boehringer Ingelheim International GmbH, AstraZeneca PLC, Mitsubishi Tanabe Pharma Corporation, Eli Lilly and Company, Johnson & Johnson, Bristol-Myers Squibb, Teva Pharmaceutical Industries Ltd., Hanmi Pharmaceuticals Co., Ltd., Eisai Co., Ltd., Biocon Limited, Cadila Pharmaceuticals Ltd

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/alpha-glucosidase-inhibitors-global-market-report

Which Region Is Projected To Lead The Alpha Glucosidase Inhibitors Market By 2025?

North America was the largest region in the alpha glucosidase inhibitors market in 2024. Middle-East is expected to be the fastest-growing region in the forecast period. The regions covered in the alpha glucosidase inhibitors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=11880&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model